Dr. Yadana Kyaw, MD

NPI: 1134393473
Total Payments
$4,662
2024 Payments
$475.47
Companies
27
Transactions
267
Medicare Patients
4,535
Medicare Billing
$392,515

Payment Breakdown by Category

Food & Beverage$4,342 (93.1%)
Education$320.46 (6.9%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,342 257 93.1%
Education $320.46 10 6.9%

Top Paying Companies

Company Total Records Latest Year
GlaxoSmithKline, LLC. $796.18 47 $0 (2024)
Genentech USA, Inc. $647.51 24 $0 (2023)
Actelion Pharmaceuticals US, Inc. $625.86 41 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $404.75 23 $0 (2024)
AstraZeneca Pharmaceuticals LP $371.04 25 $0 (2024)
Insmed, Inc. $368.02 16 $0 (2024)
Sunovion Pharmaceuticals Inc. $340.40 26 $0 (2018)
Grifols USA, LLC $143.43 10 $0 (2021)
GENZYME CORPORATION $140.90 7 $0 (2024)
Mylan Specialty L.P. $109.38 7 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $475.47 28 Actelion Pharmaceuticals US, Inc. ($174.55)
2023 $626.74 33 GlaxoSmithKline, LLC. ($100.47)
2022 $357.03 23 GlaxoSmithKline, LLC. ($123.60)
2021 $266.63 15 Boehringer Ingelheim Pharmaceuticals, Inc. ($70.39)
2020 $508.50 26 Insmed, Inc. ($201.82)
2019 $877.75 39 Genentech USA, Inc. ($314.81)
2018 $751.86 50 Genentech USA, Inc. ($265.09)
2017 $798.19 53 Sunovion Pharmaceuticals Inc. ($195.54)

All Payment Transactions

267 individual payment records from CMS Open Payments — Page 1 of 11

Date Company Product Nature Form Amount Type
11/25/2024 Merck Sharp & Dohme LLC WINREVAIR (Biological) Food and Beverage In-kind items and services $13.15 General
Category: CARDIOVASCULAR
10/15/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $21.12 General
Category: Immunology
10/14/2024 Actelion Pharmaceuticals US, Inc. UPTRAVI (Drug), OPSUMIT Food and Beverage In-kind items and services $16.53 General
Category: Cardiology
09/25/2024 GlaxoSmithKline, LLC. NUCALA (Biological) Food and Beverage In-kind items and services $18.41 General
Category: IMMUNOLOGY
09/11/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $19.94 General
Category: RESPIRATORY
09/10/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $17.33 General
Category: Cardiology
08/14/2024 Actelion Pharmaceuticals US, Inc. UPTRAVI (Drug), OPSUMIT Food and Beverage In-kind items and services $15.02 General
Category: Cardiology
07/16/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $13.83 General
Category: Cardiology
06/11/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $16.28 General
Category: Cardiology
05/28/2024 Amgen Inc. TEZSPIRE (Biological) Food and Beverage In-kind items and services $14.41 General
Category: Inflammation
05/16/2024 Actelion Pharmaceuticals US, Inc. UPTRAVI (Drug), OPSUMIT Food and Beverage In-kind items and services $17.93 General
Category: Cardiology
05/04/2024 Fisher & Paykel Healthcare Inc FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE Food and Beverage In-kind items and services $17.99 General
Category: Sleep
04/17/2024 HARMONY BIOSCIENCES LLC WAKIX (Drug) Food and Beverage Cash or cash equivalent $17.01 General
Category: Narcoplepsy
04/16/2024 Actelion Pharmaceuticals US, Inc. UPTRAVI (Drug), OPSUMIT Food and Beverage In-kind items and services $13.47 General
Category: Cardiology
03/27/2024 Actelion Pharmaceuticals US, Inc. UPTRAVI (Drug), OPSUMIT Food and Beverage In-kind items and services $16.86 General
Category: Cardiology
03/22/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $16.83 General
Category: Cardiology
02/23/2024 Merck Sharp & Dohme LLC Food and Beverage In-kind items and services $19.50 General
02/22/2024 Insmed, Inc. Arikayce (Drug) Food and Beverage In-kind items and services $23.52 General
Category: Respiratory
02/22/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $16.19 General
Category: Respiratory
02/13/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $17.00 General
Category: Cardiology
02/03/2024 PFIZER INC. PREVNAR 20 (Biological), COMIRNATY, ABRYSVO Food and Beverage In-kind items and services $17.10 General
Category: VACCINES
02/01/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $13.62 General
Category: Immunology
01/31/2024 Bayer Healthcare Pharmaceuticals Inc. Adempas (Drug) Food and Beverage In-kind items and services $16.10 General
Category: Cardio-pulmonary
01/31/2024 Actelion Pharmaceuticals US, Inc. OPSUMIT (Drug), UPTRAVI Food and Beverage In-kind items and services $13.47 General
Category: Cardiology
01/22/2024 AstraZeneca Pharmaceuticals LP ANDEXXA (Biological) Food and Beverage In-kind items and services $16.08 General
Category: Rare Disease

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 19 952 1,210 $214,007 $77,864
2022 25 1,088 1,385 $249,508 $86,802
2021 22 1,145 1,587 $305,632 $110,290
2020 30 1,350 1,723 $333,104 $117,559
Total Patients
4,535
Total Services
5,905
Medicare Billing
$392,515
Procedure Codes
104

All Medicare Procedures & Services

104 procedure records from CMS Medicare Utilization — Page 1 of 5

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes Facility 2023 124 253 $48,070 $22,729 47.3%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 89 124 $24,800 $10,393 41.9%
99291 Critical care, first 30-74 minutes Facility 2023 42 50 $20,250 $7,917 39.1%
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes Facility 2023 98 124 $16,120 $7,255 45.0%
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes Facility 2023 47 47 $16,450 $6,157 37.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 82 96 $12,960 $5,633 43.5%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 36 36 $10,980 $4,416 40.2%
94729 Test to examine how well the lungs exchange gases Office 2023 62 69 $9,660 $2,640 27.3%
94375 Test to measure rate of airflow Office 2023 95 103 $10,300 $2,546 24.7%
31624 Irrigation and suction of lung airways to obtain cells using an endoscope Facility 2023 26 27 $13,500 $1,853 13.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 17 17 $3,400 $1,306 38.4%
71046 X-ray of chest, 2 views Office 2023 63 66 $7,590 $1,297 17.1%
31500 Emergent insertion of breathing tube into windpipe using an endoscope Facility 2023 12 12 $5,400 $1,276 23.6%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Office 2023 21 21 $3,045 $570.57 18.7%
36415 Insertion of needle into vein for collection of blood sample Office 2023 27 54 $540.00 $453.60 84.0%
G0008 Administration of influenza virus vaccine Office 2023 14 14 $420.00 $392.70 93.5%
94727 Test to determine lung volumes using gas dilution or washout Office 2023 11 11 $1,265 $338.36 26.7%
94060 Test to measure expiratory airflow and volume changes before and after medication administration Facility 2023 25 25 $3,567 $192.25 5.4%
94726 Test to determine lung volumes using sensors Facility 2023 20 20 $1,538 $179.80 11.7%
94729 Test to examine how well the lungs exchange gases Facility 2023 24 24 $2,452 $159.60 6.5%
99152 Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes Facility 2023 17 17 $1,700 $159.12 9.4%
99233 Follow-up hospital inpatient care per day, typically 35 minutes Facility 2022 135 273 $51,870 $20,931 40.4%
99232 Follow-up hospital inpatient care per day, typically 25 minutes Facility 2022 152 227 $29,510 $12,203 41.4%
99223 Initial hospital inpatient care per day, typically 70 minutes Facility 2022 68 68 $23,800 $10,032 42.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 88 108 $21,600 $9,632 44.6%

About Dr. Yadana Kyaw, MD

Dr. Yadana Kyaw, MD is a Critical Care Medicine healthcare provider based in Southaven, Mississippi. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/17/2008. The National Provider Identifier (NPI) number assigned to this provider is 1134393473.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Yadana Kyaw, MD has received a total of $4,662 in payments from pharmaceutical and medical device companies, with $475.47 received in 2024. These payments were reported across 267 transactions from 27 companies. The most common payment nature is "Food and Beverage" ($4,342).

As a Medicare-enrolled provider, Kyaw has provided services to 4,535 Medicare beneficiaries, totaling 5,905 services with total Medicare billing of $392,515. Data is available for 4 years (2020–2023), covering 104 distinct procedure/service records.

Practice Information

  • Specialty Critical Care Medicine
  • Other Specialties Critical Care Medicine, Pulmonary Disease
  • Location Southaven, MS
  • Active Since 04/17/2008
  • Last Updated 03/28/2023
  • Taxonomy Code 207RC0200X
  • Entity Type Individual
  • NPI Number 1134393473

Products in Payments

  • Arikayce (Drug) $351.78
  • TRELEGY ELLIPTA (Drug) $346.53
  • UPTRAVI (Drug) $291.33
  • OFEV (Drug) $252.79
  • Xolair (Biological) $245.67
  • OPSUMIT (Drug) $231.36
  • NUCALA (Biological) $187.36
  • UTIBRON (Drug) $176.44
  • Esbriet (Biological) $163.59
  • DUPIXENT (Biological) $140.90
  • Utibron (Drug) $136.00
  • OPSUMIT MACITENTAN (Drug) $103.17
  • STIOLTO (Drug) $102.12
  • Prolastin-C Liquid (Biological) $94.89
  • SYMBICORT (Drug) $89.40
  • WAKIX (Drug) $87.23
  • GIAPREZA (Drug) $79.31
  • ANORO (Drug) $72.70
  • TEZSPIRE (Biological) $69.35
  • XOLAIR (Biological) $64.20

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Critical Care Medicine Doctors in Southaven